Clearance of the original hepatitis B virus YMDD-motif mutants with emergence of distinct lamivudine-resistant mutants during prolonged lamivudine therapy

Hepatology

Volumn 31, Issue 6, 2000, Pages 1318-1326

  Yeh, Chau Ting ^a,b   Chien, Rong Nan ^a   Cengljhu, Chia Ming ^a   Liaw, Yun Fan ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; HEPATITIS B SURFACE ANTIGEN; LAMIVUDINE; VIRUS DNA;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CLINICAL TRIAL; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR CLONING; MULTICENTER STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SITE DIRECTED MUTAGENESIS; VIRUS HEPATITIS; VIRUS MUTANT;

EID: 0034040297     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2000.7296     Document Type: Article

References (9)

1. Chang CN, Dkalski V, Zhou JH, Cheng YC. Biochemical pharmacology of (+)- and (-)-2′, 3′-dedeoxy-3′-thiacytidine as anti-hepatitis B virus agents. J Biol Chem 1992;31:22414-22420.
2. Doong SL, Tsai CH, Schinazi RF, Liotta DC, Cheng YC. Inhibition of the replication of hepatitis B virus in vitro by 2′, 3′-dideoxy-3′-thiacytidine and related analogues. Proc Natl Acad Sci U S A 1991;19:8495-8499.
3. Severni A, Liu X, Wilson JS, Tyrrell DL. Mechanism of inhibition of duck hepatitis B virus polymerase by (-)-β-L-2′, 3′-dedeoxy-3′-thiacytidine. Antimicrob Agents Chemother 1995;39:1430-1435.
4. Xie H, Voronkov M, Liotta DC, Korba BA, Schinazi RF, Richman DD, Hosteller KY. Phosphatidyl-2′, 3′-dedeoxy-3′-thiacytidine: synthesis and activity in hepatitis B and HIV-1-infected cells. Antiviral Res 1995;28:113-120.
5. Lai CL, Chien RN, Leung NW, Chang TT, Guan R, Tai DI, Ng KY, et al. A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study. N Engl J Med 1998;339:61-68.
6. Ben-Ari Z, Shmueli D, Mor E, Shapira Z, Tur-Kaspa R. Beneficial effect of lamivudine in recurrent hepatitis B after liver transplantation. Transplantation 1997;3:393-396.
7. Dienstag JL, Perrillo RP, Schiff ER, Bartholomew M, Vicary C, Rubin M. A preliminary trial of lamivudine for chronic hepatitis B infection. N Engl J Med 1995;25:1657-1661.
8. Mason WS, Cullen J, Moraleda G, Saputelli J, Aldrich CE, Miller DS, Tennant B, et al. Lamivudine therapy of WHV-infected woodchucks. Virology 1998;245:18-32.
9. Moraleda G, Saputelli J, Aldrich CE, Averett D, Condreay L, Mason WS. Lack of effect of antiviral therapy in nondividing hepatocyte cultures on the closed circular DNA of woodchuck hepatitis virus. J Virol 1997;71:9392-9399.